SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 144 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,328 | -80.0% | 10,252 | -72.9% | 0.00% | – |
| Q1 2023 | $66,486 | -99.2% | 37,776 | -94.4% | 0.00% | -100.0% |
| Q1 2021 | $8,523,000 | +140.1% | 680,200 | +172.1% | 0.04% | +185.7% |
| Q2 2018 | $3,550,000 | -65.9% | 250,000 | -63.9% | 0.01% | -69.6% |
| Q3 2017 | $10,400,000 | +230.4% | 693,300 | +93.8% | 0.05% | +155.6% |
| Q2 2017 | $3,148,000 | +49.4% | 357,705 | +2.7% | 0.02% | +12.5% |
| Q1 2016 | $2,107,000 | -61.6% | 348,200 | -42.0% | 0.02% | -64.4% |
| Q4 2015 | $5,481,000 | +3325.6% | 600,300 | +2021.2% | 0.04% | +4400.0% |
| Q3 2015 | $160,000 | -95.5% | 28,300 | -91.2% | 0.00% | -96.0% |
| Q2 2015 | $3,552,000 | +15.5% | 320,300 | +63.3% | 0.02% | +19.0% |
| Q1 2015 | $3,075,000 | +28.0% | 196,100 | +24.1% | 0.02% | +23.5% |
| Q4 2014 | $2,403,000 | -80.3% | 158,000 | -86.0% | 0.02% | -81.5% |
| Q3 2014 | $12,186,000 | +1.2% | 1,129,900 | +43.2% | 0.09% | +19.5% |
| Q2 2014 | $12,047,000 | – | 788,900 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |